Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-01-05

Clinical Trial Update: Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing standard abciximab versus ClearWay-infused abciximab with thrombectomy in ST-elevation myocardial infarction; current trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abciximab (abciximab)
  • ClearWay-infused Abciximab

Snippet

Sponsor: CLI Foundation | Conditions: ST-elevation Myocardial Infarction | Phase 4 | Status: UNKNOWN